{
    "url_original": "https://www.wsj.com/articles/cdc-advisers-review-blood-clotting-risk-associated-with-j-js-covid-19-vaccine-11639662363?mod=business_lead_pos6",
    "url": "cdc-advisers-review-blood-clotting-risk-associated-with-j-js-covid-19-vaccine-11639662363",
    "title": "CDC Advisers Recommend Pfizer, Moderna Covid-19 Vaccines Over J&J’s",
    "sub_head": "Rate of cases of rare blood-clotting condition associated with Johnson & Johnson’s shot is higher than initially thought",
    "category_1": "Business",
    "category_2": "Health Care",
    "time": "2021-12-16 15:56:00",
    "body": "U.S. vaccine advisers recommended adults take a Covid-19 vaccine from  Pfizer Inc.  or  Moderna Inc.  over  Johnson & Johnson ’s  after health authorities said the rate of a rare but serious blood-clotting condition was higher than previously detected.<br />The Advisory Committee on Immunization Practices voted 15 to 0 to make the recommendation Thursday after hearing updates from Centers for Disease Control and Prevention officials on reports of J&J vaccine recipients experiencing blood clots combined with low blood-platelet levels."
}